Stephanie L Greville-Heygate1,2,3, Tom Maishman1, William J Tapper1, Ramsey I Cutress1, Ellen Copson1, Alison M Dunning4, Linda Haywood5, Louise J Jones5, Diana M Eccles1,2. 1. Faculty of Medicine, University of Southampton, Southampton, United Kingdom. 2. Wessex Clinical Genetics Service, University Hospitals Southampton National Health Service Foundation Trust, Southampton, United Kingdom. 3. Health Education England, Leeds, United Kingdom. 4. Department of Oncology and Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom. 5. Tumour Biology Department, Institute of Cancer, Barts & The London School of Medicine & Dentistry, London, United Kingdom.
Abstract
PURPOSE: Checkpoint kinase 2 (CHEK2) is frequently included in multigene panels. We describe the associated outcomes among carriers of CHEK2 pathogenic variants in young patients with symptomatic breast cancer. PATIENTS AND METHODS: Participants (N = 2,344) in the Prospective Outcomes in Sporadic Versus Hereditary Breast Cancer study had a diagnosis of primary invasive breast cancer at age ≤ 40 years. Summary statistics were used to compare tumor characteristics among CHEK2+ carriers with those who were CHEK2-. Kaplan-Meier curves were used to demonstrate overall survival (OS) and distant disease-free survival. RESULTS: Overall, 53 of the 2,344 participants (2.3%) had a pathogenic CHEK2 variant. CHEK2+-associated tumors were significantly more likely to be grade 2, estrogen receptor and progesterone receptor-positive compared with CHEK2- tumors (grade 2, n = 28 of 52 [53.8%] v n = 803 of 2,229 [36.0%]; P = .029). CHEK2-associated tumors were significantly more likely to have nodal involvement (N1, n = 37 of 53 [69.8%] v 1,169 of 2,253 [51.9%]; P = .0098) and demonstrated a trend toward multifocality. A higher proportion of participants with CHEK2+ variants with invasive breast cancer were obese than were those with CHEK2- variant (28.3% v 18.8%; P = .039). Univariate and multivariable analyses revealed that OS and distant disease-free survival were significantly worse in CHEK2+ versus CHEK2- carriers (OS hazard ratio, 1.58; 95% CI, 1.01 to 2.48; P = .043). CONCLUSION: This work highlights the adverse prognosis associated with breast cancer in carriers of CHEK2 pathogenic variants. It also identifies a potential association among obesity, family history, and breast cancer risk in young CHEK2 gene carriers.
PURPOSE:Checkpoint kinase 2 (CHEK2) is frequently included in multigene panels. We describe the associated outcomes among carriers of CHEK2 pathogenic variants in young patients with symptomatic breast cancer. PATIENTS AND METHODS: Participants (N = 2,344) in the Prospective Outcomes in Sporadic Versus Hereditary Breast Cancer study had a diagnosis of primary invasive breast cancer at age ≤ 40 years. Summary statistics were used to compare tumor characteristics among CHEK2+ carriers with those who were CHEK2-. Kaplan-Meier curves were used to demonstrate overall survival (OS) and distant disease-free survival. RESULTS: Overall, 53 of the 2,344 participants (2.3%) had a pathogenic CHEK2 variant. CHEK2+-associated tumors were significantly more likely to be grade 2, estrogen receptor and progesterone receptor-positive compared with CHEK2- tumors (grade 2, n = 28 of 52 [53.8%] v n = 803 of 2,229 [36.0%]; P = .029). CHEK2-associated tumors were significantly more likely to have nodal involvement (N1, n = 37 of 53 [69.8%] v 1,169 of 2,253 [51.9%]; P = .0098) and demonstrated a trend toward multifocality. A higher proportion of participants with CHEK2+ variants with invasive breast cancer were obese than were those with CHEK2- variant (28.3% v 18.8%; P = .039). Univariate and multivariable analyses revealed that OS and distant disease-free survival were significantly worse in CHEK2+ versus CHEK2- carriers (OS hazard ratio, 1.58; 95% CI, 1.01 to 2.48; P = .043). CONCLUSION: This work highlights the adverse prognosis associated with breast cancer in carriers of CHEK2 pathogenic variants. It also identifies a potential association among obesity, family history, and breast cancer risk in young CHEK2 gene carriers.
Authors: Cezary Cybulski; Dominika Wokołorczyk; Anna Jakubowska; Tomasz Huzarski; Tomasz Byrski; Jacek Gronwald; Bartłomiej Masojć; Tadeusz Deebniak; Bohdan Górski; Paweł Blecharz; Steven A Narod; Jan Lubiński Journal: J Clin Oncol Date: 2011-08-29 Impact factor: 44.544
Authors: Marjanka K Schmidt; Rob A E M Tollenaar; Sanne R de Kemp; Annegien Broeks; Cees J Cornelisse; Vincent T H B M Smit; Johannes L Peterse; Flora E van Leeuwen; Laura J Van't Veer Journal: J Clin Oncol Date: 2006-11-28 Impact factor: 44.544
Authors: B K Eccles; E R Copson; R I Cutress; T Maishman; D G Altman; P Simmonds; S M Gerty; L Durcan; L Stanton; D M Eccles Journal: Br J Surg Date: 2015-05-20 Impact factor: 6.939
Authors: G H de Bock; M Schutte; E M M Krol-Warmerdam; C Seynaeve; J Blom; C T M Brekelmans; H Meijers-Heijboer; C J van Asperen; C J Cornelisse; P Devilee; R A E M Tollenaar; J G M Klijn Journal: J Med Genet Date: 2004-10 Impact factor: 6.318
Authors: Ellen Copson; Bryony Eccles; Tom Maishman; Sue Gerty; Louise Stanton; Ramsey I Cutress; Douglas G Altman; Lorraine Durcan; Peter Simmonds; Gill Lawrence; Louise Jones; Judith Bliss; Diana Eccles Journal: J Natl Cancer Inst Date: 2013-05-30 Impact factor: 13.506
Authors: Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm Journal: Genet Med Date: 2015-03-05 Impact factor: 8.822
Authors: Diana Eccles; Sue Gerty; Peter Simmonds; Victoria Hammond; Sarah Ennis; Douglas G Altman Journal: BMC Cancer Date: 2007-08-15 Impact factor: 4.430
Authors: Melissa C Southey; David E Goldgar; Robert Winqvist; Katri Pylkäs; Fergus Couch; Marc Tischkowitz; William D Foulkes; Joe Dennis; Kyriaki Michailidou; Elizabeth J van Rensburg; Tuomas Heikkinen; Heli Nevanlinna; John L Hopper; Thilo Dörk; Kathleen Bm Claes; Jorge Reis-Filho; Zhi Ling Teo; Paolo Radice; Irene Catucci; Paolo Peterlongo; Helen Tsimiklis; Fabrice A Odefrey; James G Dowty; Marjanka K Schmidt; Annegien Broeks; Frans B Hogervorst; Senno Verhoef; Jane Carpenter; Christine Clarke; Rodney J Scott; Peter A Fasching; Lothar Haeberle; Arif B Ekici; Matthias W Beckmann; Julian Peto; Isabel Dos-Santos-Silva; Olivia Fletcher; Nichola Johnson; Manjeet K Bolla; Elinor J Sawyer; Ian Tomlinson; Michael J Kerin; Nicola Miller; Federik Marme; Barbara Burwinkel; Rongxi Yang; Pascal Guénel; Thérèse Truong; Florence Menegaux; Marie Sanchez; Stig Bojesen; Sune F Nielsen; Henrik Flyger; Javier Benitez; M Pilar Zamora; Jose Ignacio Arias Perez; Primitiva Menéndez; Hoda Anton-Culver; Susan Neuhausen; Argyrios Ziogas; Christina A Clarke; Hermann Brenner; Volker Arndt; Christa Stegmaier; Hiltrud Brauch; Thomas Brüning; Yon-Dschun Ko; Taru A Muranen; Kristiina Aittomäki; Carl Blomqvist; Natalia V Bogdanova; Natalia N Antonenkova; Annika Lindblom; Sara Margolin; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Amanda B Spurdle; kConFab Investigators; Els Wauters; Dominiek Smeets; Benoit Beuselinck; Giuseppe Floris; Jenny Chang-Claude; Anja Rudolph; Petra Seibold; Dieter Flesch-Janys; Janet E Olson; Celine Vachon; Vernon S Pankratz; Catriona McLean; Christopher A Haiman; Brian E Henderson; Fredrick Schumacher; Loic Le Marchand; Vessela Kristensen; Grethe Grenaker Alnæs; Wei Zheng; David J Hunter; Sara Lindstrom; Susan E Hankinson; Peter Kraft; Irene Andrulis; Julia A Knight; Gord Glendon; Anna Marie Mulligan; Arja Jukkola-Vuorinen; Mervi Grip; Saila Kauppila; Peter Devilee; Robert A E M Tollenaar; Caroline Seynaeve; Antoinette Hollestelle; Montserrat Garcia-Closas; Jonine Figueroa; Stephen J Chanock; Jolanta Lissowska; Kamila Czene; Hatef Darabi; Mikael Eriksson; Diana M Eccles; Sajjad Rafiq; William J Tapper; Sue M Gerty; Maartje J Hooning; John W M Martens; J Margriet Collée; Madeleine Tilanus-Linthorst; Per Hall; Jingmei Li; Judith S Brand; Keith Humphreys; Angela Cox; Malcolm W R Reed; Craig Luccarini; Caroline Baynes; Alison M Dunning; Ute Hamann; Diana Torres; Hans Ulrich Ulmer; Thomas Rüdiger; Anna Jakubowska; Jan Lubinski; Katarzyna Jaworska; Katarzyna Durda; Susan Slager; Amanda E Toland; Christine B Ambrosone; Drakoulis Yannoukakos; Anthony Swerdlow; Alan Ashworth; Nick Orr; Michael Jones; Anna González-Neira; Guillermo Pita; M Rosario Alonso; Nuria Álvarez; Daniel Herrero; Daniel C Tessier; Daniel Vincent; Francois Bacot; Jacques Simard; Martine Dumont; Penny Soucy; Rosalind Eeles; Kenneth Muir; Fredrik Wiklund; Henrik Gronberg; Johanna Schleutker; Børge G Nordestgaard; Maren Weischer; Ruth C Travis; David Neal; Jenny L Donovan; Freddie C Hamdy; Kay-Tee Khaw; Janet L Stanford; William J Blot; Stephen Thibodeau; Daniel J Schaid; Joseph L Kelley; Christiane Maier; Adam S Kibel; Cezary Cybulski; Lisa Cannon-Albright; Katja Butterbach; Jong Park; Radka Kaneva; Jyotsna Batra; Manuel R Teixeira; Zsofia Kote-Jarai; Ali Amin Al Olama; Sara Benlloch; Stefan P Renner; Arndt Hartmann; Alexander Hein; Matthias Ruebner; Diether Lambrechts; Els Van Nieuwenhuysen; Ignace Vergote; Sandrina Lambretchs; Jennifer A Doherty; Mary Anne Rossing; Stefan Nickels; Ursula Eilber; Shan Wang-Gohrke; Kunle Odunsi; Lara E Sucheston-Campbell; Grace Friel; Galina Lurie; Jeffrey L Killeen; Lynne R Wilkens; Marc T Goodman; Ingo Runnebaum; Peter A Hillemanns; Liisa M Pelttari; Ralf Butzow; Francesmary Modugno; Robert P Edwards; Roberta B Ness; Kirsten B Moysich; Andreas du Bois; Florian Heitz; Philipp Harter; Stefan Kommoss; Beth Y Karlan; Christine Walsh; Jenny Lester; Allan Jensen; Susanne Krüger Kjaer; Estrid Høgdall; Bernard Peissel; Bernardo Bonanni; Loris Bernard; Ellen L Goode; Brooke L Fridley; Robert A Vierkant; Julie M Cunningham; Melissa C Larson; Zachary C Fogarty; Kimberly R Kalli; Dong Liang; Karen H Lu; Michelle A T Hildebrandt; Xifeng Wu; Douglas A Levine; Fanny Dao; Maria Bisogna; Andrew Berchuck; Edwin S Iversen; Jeffrey R Marks; Lucy Akushevich; Daniel W Cramer; Joellen Schildkraut; Kathryn L Terry; Elizabeth M Poole; Meir Stampfer; Shelley S Tworoger; Elisa V Bandera; Irene Orlow; Sara H Olson; Line Bjorge; Helga B Salvesen; Anne M van Altena; Katja K H Aben; Lambertus A Kiemeney; Leon F A G Massuger; Tanja Pejovic; Yukie Bean; Angela Brooks-Wilson; Linda E Kelemen; Linda S Cook; Nhu D Le; Bohdan Górski; Jacek Gronwald; Janusz Menkiszak; Claus K Høgdall; Lene Lundvall; Lotte Nedergaard; Svend Aage Engelholm; Ed Dicks; Jonathan Tyrer; Ian Campbell; Iain McNeish; James Paul; Nadeem Siddiqui; Rosalind Glasspool; Alice S Whittemore; Joseph H Rothstein; Valerie McGuire; Weiva Sieh; Hui Cai; Xiao-Ou Shu; Rachel T Teten; Rebecca Sutphen; John R McLaughlin; Steven A Narod; Catherine M Phelan; Alvaro N Monteiro; David Fenstermacher; Hui-Yi Lin; Jennifer B Permuth; Thomas A Sellers; Y Ann Chen; Ya-Yu Tsai; Zhihua Chen; Aleksandra Gentry-Maharaj; Simon A Gayther; Susan J Ramus; Usha Menon; Anna H Wu; Celeste L Pearce; David Van Den Berg; Malcolm C Pike; Agnieszka Dansonka-Mieszkowska; Joanna Plisiecka-Halasa; Joanna Moes-Sosnowska; Jolanta Kupryjanczyk; Paul Dp Pharoah; Honglin Song; Ingrid Winship; Georgia Chenevix-Trench; Graham G Giles; Sean V Tavtigian; Doug F Easton; Roger L Milne Journal: J Med Genet Date: 2016-09-05 Impact factor: 6.318
Authors: Siddhartha Yadav; Chunling Hu; Katherine L Nathanson; Jeffrey N Weitzel; David E Goldgar; Peter Kraft; Rohan D Gnanaolivu; Jie Na; Hongyan Huang; Nicholas J Boddicker; Nicole Larson; Chi Gao; Song Yao; Clarice Weinberg; Celine M Vachon; Amy Trentham-Dietz; Jack A Taylor; Dale R Sandler; Alpa Patel; Julie R Palmer; Janet E Olson; Susan Neuhausen; Elena Martinez; Sara Lindstrom; James V Lacey; Allison W Kurian; Esther M John; Christopher Haiman; Leslie Bernstein; Paul W Auer; Hoda Anton-Culver; Christine B Ambrosone; Rachid Karam; Elizabeth Chao; Amal Yussuf; Tina Pesaran; Jill S Dolinsky; Steven N Hart; Holly LaDuca; Eric C Polley; Susan M Domchek; Fergus J Couch Journal: J Clin Oncol Date: 2021-10-21 Impact factor: 44.544
Authors: Joanna Tomiczek-Szwiec; Marek Szwiec; Michal Falco; Cezary Cybulski; Dominika Wokolorczyk; Anna Jakubowska; Jacek Gronwald; Malgorzata Stawicka; Dariusz Godlewski; Ewa Kilar; Elzbieta Marczyk; Monika Siołek; Rafal Wiśniowski; Olga Haus; Robert Sibilski; Lubomir Bodnar; Ping Sun; Steven A Narod; Jan Lubinski; Tomasz Huzarski Journal: Br J Cancer Date: 2022-03-07 Impact factor: 9.075